Moderna (MRNA) Stock Climbs as Company Launches Ebola Vaccine Trial in Canada
Key Highlights Moderna initiates Phase 1 clinical trial in Canada for Bundibugyo Ebola vaccine candidate mRNA-1469. Canadian study will evaluate safety, tolerability, and immunogenicity in ap









